Clinical Trial Search Results for "MERLIN-TIMI 36"

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Skene, A., McCabe, C. H., Braunwald, E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial Am Heart J. 2006;151(6):1186 e1-9. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Murphy, S. A., Budaj, A., Varshavsky, S., Wolff, A. A., Skene, A., McCabe, C. H., Braunwald, E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA. 2007;297(16):1775-83. Abstract

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W., Gersh, B. J., McCabe, C. H., Braunwald, E. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2007;116(15):1647-52. Abstract

Arnold, S. V., Morrow, D. A., Wang, K., Lei, Y., Mahoney, E. M., Scirica, B. M., Braunwald, E., Cohen, D. J. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial Circ Cardiovasc Qual Outcomes. 2008;1(2):107-15. Abstract

Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., Chan, P. S. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial Circulation Cardiovascular quality and outcomes. 2009;2(4):344-53. Abstract

Morrow, D. A., Scirica, B. M., Chaitman, B. R., McGuire, D. K., Murphy, S. A., Karwatowska-Prokopczuk, E., McCabe, C. H., Braunwald, E. Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial Circulation. 2009;119(15):2032-9. Abstract

Scirica, B. M., Morrow, D. A., Budaj, A., Dalby, A. J., Mohanavelu, S., Qin, J., Aroesty, J., Hedgepeth, C. M., Stone, P. H., Braunwald, E. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2009;53(16):1411-21. Abstract

Syed, Z., Sung, P., Scirica, B. M., Morrow, D. A., Stultz, C. M., Guttag, J. V. Spectral energy of ECG morphologic differences to predict death Cardiovasc Eng. 2009;9(1):18-26. Abstract

Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial Journal of the American College of Cardiology. 2009;53(17):1510-6. Abstract

Chisholm, J. W., Goldfine, A. B., Dhalla, A. K., Braunwald, E., Morrow, D. A., Karwatowska-Prokopczuk, E., Belardinelli, L. Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome Diabetes care. 2010;33(6):1163-8. Abstract

Mega, J. L., Hochman, J. S., Scirica, B. M., Murphy, S. A., Sloan, S., McCabe, C. H., Merlini, P., Morrow, D. A. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation. 2010;121(16):1809-17. Abstract

Morrow, D. A., Scirica, B. M., Sabatine, M. S., de Lemos, J. A., Murphy, S. A., Jarolim, P., Theroux, P., Bode, C., Braunwald, E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2010;55(12):1189-96. Abstract

Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W., Morrow, D. A. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2010;122(5):455-62. Abstract

Harkness, J. R., Morrow, D. A., Braunwald, E., Ren, F., Lopez-Sendon, J., Bode, C., Budaj, A., Scirica, B. M. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial) American journal of cardiology. 2011;108(10):1373-81. Abstract

Kadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart. 2011;97(21):1782-7. Abstract

Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., de Lemos, J. L., Braunwald, E., Morrow, D. A. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial European heart journal. 2011;32(6):697-705. Abstract

Bonaca, M. P., Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., Chamberlin, J. S., Rhodes, D. W., Southwick, P. C., Braunwald, E., Morrow, D. A. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2012;60(4):332-8. Abstract

Kohli, P., Bonaca, M. P., Kakkar, R., Kudinova, A. Y., Scirica, B. M., Sabatine, M. S., Murphy, S. A., Braunwald, E., Lee, R. T., Morrow, D. A. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Clinical chemistry. 2012;58(1):257-66. Abstract

Roysland, R., Bonaca, M. P., Omland, T., Sabatine, M., Murphy, S. A., Scirica, B. M., Bjerre, M., Flyvbjerg, A., Braunwald, E., Morrow, D. A. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes Heart. 2012;98(10):786-91. Abstract

Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 Eur Heart J Acute Cardiovasc Care. 2014:Epub ahead of print. Abstract

Nieminen, T., Scirica, B. M., Pegler, J. R., Tavares, C., Pagotto, V. P., Kanas, A. F., Sobrado, M. F., Nearing, B. D., Umez-Eronini, A. A., Morrow, D. A., Belardinelli, L., Verrier, R. L. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo Am J Cardiol. 2014;NA(NA):NA. Abstract

O'Malley, R. G., Bonaca, M. P., Scirica, B. M., Murphy, S. A., Jarolim, P., Sabatine, M. S., Braunwald, E., Morrow, D. A. Prognostic Performance of Multiple Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN-TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol. 2014;63(16):1644-53. Abstract

Rhee, J. W., Wiviott, S. D., Scirica, B. M., Gibson, C. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A., Mega, J. L. Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Syndrome Clin Cardiol. 2014;NA(NA):NA. Abstract